pubmed-article:8958473 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8958473 | lifeskim:mentions | umls-concept:C0032227 | lld:lifeskim |
pubmed-article:8958473 | lifeskim:mentions | umls-concept:C1512505 | lld:lifeskim |
pubmed-article:8958473 | lifeskim:mentions | umls-concept:C0034845 | lld:lifeskim |
pubmed-article:8958473 | lifeskim:mentions | umls-concept:C0140080 | lld:lifeskim |
pubmed-article:8958473 | lifeskim:mentions | umls-concept:C0444186 | lld:lifeskim |
pubmed-article:8958473 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:8958473 | lifeskim:mentions | umls-concept:C1947932 | lld:lifeskim |
pubmed-article:8958473 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:8958473 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:8958473 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:8958473 | pubmed:dateCreated | 1997-3-6 | lld:pubmed |
pubmed-article:8958473 | pubmed:abstractText | Smear preparations were made from cells harvested from pleural fluid from 90 patients with breast cancer and stained for transferrin receptor (TRFr) and insulin-like growth factor-I receptor (IGF-Ir) using an immunocytochemical technique. The results were correlated with those from 36 benign effusions smears. In malignant smears from the breast cancer cases TRFr was demonstrated in 84.4% of the cellular deposits and IGF-Ir in 91.1%. TRFr was demonstrated in two (11%) of the tuberculous effusion smears and in six (100%) effusions from patients with collagen disease. IGF-Ir was not demonstrated in any of the smears from patients with benign disease. The sensitivity and specificity of TRFr staining were 84.4% and 77.7%, respectively, and for IGF-Ir staining were 91.1% and 100%, respectively. The underlying metabolic changes in the tumour cells which give rise to positive staining with these markers are discussed. | lld:pubmed |
pubmed-article:8958473 | pubmed:language | eng | lld:pubmed |
pubmed-article:8958473 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8958473 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8958473 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8958473 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8958473 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8958473 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8958473 | pubmed:month | Dec | lld:pubmed |
pubmed-article:8958473 | pubmed:issn | 0956-5507 | lld:pubmed |
pubmed-article:8958473 | pubmed:author | pubmed-author:Athanassiades... | lld:pubmed |
pubmed-article:8958473 | pubmed:author | pubmed-author:MavrikakisMM | lld:pubmed |
pubmed-article:8958473 | pubmed:author | pubmed-author:KyrkouKK | lld:pubmed |
pubmed-article:8958473 | pubmed:author | pubmed-author:Konstantopoul... | lld:pubmed |
pubmed-article:8958473 | pubmed:author | pubmed-author:Athanassiadou... | lld:pubmed |
pubmed-article:8958473 | pubmed:author | pubmed-author:PetrakakouEE | lld:pubmed |
pubmed-article:8958473 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8958473 | pubmed:volume | 7 | lld:pubmed |
pubmed-article:8958473 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8958473 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8958473 | pubmed:pagination | 400-5 | lld:pubmed |
pubmed-article:8958473 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:meshHeading | pubmed-meshheading:8958473-... | lld:pubmed |
pubmed-article:8958473 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8958473 | pubmed:articleTitle | Expression of insulin-like growth factor-I receptor and transferrin receptor by breast cancer cells in pleural effusion smears. | lld:pubmed |
pubmed-article:8958473 | pubmed:affiliation | Department of Pathology, Athens University Medical School, Greece. | lld:pubmed |
pubmed-article:8958473 | pubmed:publicationType | Journal Article | lld:pubmed |